Lupin CEO Highlights Structural Support For Generics Pricing, Sees gMyrbetriq Relaunch

Liraglutide, Pegfilgrastim Launches In FY26

Revenues
Lupin Expects Increased Revenues From Higher Structural Support, New Launches • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip